KMT2A and leukemia: Here, we characterized a Drosophila model, where expression of the human leukemic oncogene MLL-AF4 results in a leukemia-like phenotype that can be rescued by genetic or pharmacologic targeting of components required for leukemia development in mammalian model systems of MLL-r leukemia.